trial · primary record
Prednisone treatment
Giant Cell Arteritis
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 230 |
| Primary completion | 2026-03-27 |
| Primary endpoint | Percentage of patients alive without relapse after initial remission or deviation from the scheduled regimen of prednisone |
| Registry ID | NCT03892785 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:04.866Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03892785
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.